ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
23andMe Holding Company

23andMe Holding Company (ME)

3.371
0.221
( 7.02% )
Updated: 11:33:11

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
3.371
Bid
3.37
Ask
3.39
Volume
158,498
3.10 Day's Range 3.39
2.655 52 Week Range 20.40
Market Cap
Previous Close
3.15
Open
3.15
Last Trade
11
@
3.3707
Last Trade Time
11:33:50
Financial Volume
US$ 521,934
VWAP
3.293
Average Volume (3m)
2,134,055
Shares Outstanding
26,117,997
Dividend Yield
-
PE Ratio
-0.13
Earnings Per Share (EPS)
-25.53
Revenue
219.64M
Net Profit
-666.7M

About 23andMe Holding Company

23andMe is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic t... 23andMe is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. More than 80% of 23andMe customers voluntarily elect to share their de-identified genetic data with the company, which is used to develop future reports. In 2018, GlaxoSmithKline made an equity investment in the company, entering a five-year collaborative agreement with 23andMe to develop drug candidates. Show more

Sector
Pharmaceutical Preparations
Industry
Blank Checks
Website
Headquarters
Wilmington, Delaware, USA
Founded
2021
23andMe Holding Company is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ME. The last closing price for 23andMe was US$3.15. Over the last year, 23andMe shares have traded in a share price range of US$ 2.655 to US$ 20.40.

23andMe currently has 26,117,997 shares outstanding. The market capitalization of 23andMe is US$82.27 million. 23andMe has a price to earnings ratio (PE ratio) of -0.13.

ME Latest News

23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation

SUNNYVALE, Calif. and SAN DIEGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, and Mirador Therapeutics, a...

23andMe Reports Second Quarter Fiscal Year 2025 Financial Results

SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, reported its financial results for the second...

23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future

Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 million Discontinues development of therapeutics division and commences strategic alternatives process for all...

CORRECTION - 23andMe to Report Q2 FY2025 Financial Results

SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- An earlier release under the same headline should have noted 23andMe Holding Co. (Nasdaq: ME) (23andMe) will report financial results for the...

23andMe to Report Q2 FY2025 Financial Results

SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, announced today that it will report...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.849-20.11848341234.224.22992.6559661243.22752709CS
4-1.369-28.88185654014.745.3482.6554308883.85561066CS
12-2.829-45.62903225816.27.882.65521340556.1782923CS
26-7.565-69.175201170410.93612.3222.65531625287.72932502CS
52-14.227-80.84441413817.59820.42.655462816611.17432406CS
156-196.629-98.3145200202.5622.655358186638.79317474CS
260-128.429-97.4423368741131.8273.62.655283301252.27612051CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WORXSCWorx Corporation
US$ 1.96
(100.00%)
116.62M
CRNCCerence Inc
US$ 5.11
(81.21%)
40.31M
SPAISafe Pro Group Inc
US$ 4.43
(38.44%)
39.81M
QUBTQuantum Computing Inc
US$ 4.98
(35.33%)
103.76M
IBGInnovation Beverage Group Limited
US$ 1.0499
(32.70%)
10.14M
GLXGGalaxy Payroll Group Ltd
US$ 1.84
(-52.94%)
1.63M
WCTWellchange Holdings Company Limited
US$ 1.6248
(-51.06%)
809.71k
SKKSKK Holdings Limited
US$ 2.575
(-43.53%)
10.05M
PYXSPyxis Oncology Inc
US$ 2.165
(-43.32%)
10.72M
BLRXBioLineRx Ltd
US$ 0.3316
(-39.18%)
7.6M
CDTConduit Pharmaceuticals Inc
US$ 0.1179
(27.74%)
519.29M
NVDANVIDIA Corporation
US$ 144.4101
(-1.01%)
236.42M
AKTSAkoustis Technologies Inc
US$ 0.1029
(18.14%)
188.47M
ELABElevai Labs Inc
US$ 0.0202
(-5.61%)
182.86M
WORXSCWorx Corporation
US$ 1.9699
(101.01%)
115.72M

ME Discussion

View Posts
Monksdream Monksdream 1 month ago
ME new 52 weeek low
πŸ‘οΈ0
Monksdream Monksdream 1 month ago
ME new 52 week
πŸ‘οΈ0
Monksdream Monksdream 1 month ago
ME new 52 week
πŸ‘οΈ0
Pisd Pisd 2 months ago
Independent Directors of 23andMe Resign from Board
September 17 2024 - 4:26PM


The independent directors of the Board of 23andMe Holding Co. (Nasdaq: ME), today sent the following letter to Anne Wojcicki, Chief Executive Officer, Co-Founder, and Chair of the Board of Directors of 23andMe, in which the independent directors have provided their resignation from the Board, effective immediately:

Dear Anne,

We, the independent directors of the 23andMe Board, hereby tender our resignations, effective immediately.

After months of work, we have yet to receive from you a fully financed, fully diligenced, actionable proposal that is in the best interests of the non-affiliated shareholders. We believe the Special Committee and the Board have provided ample time for you to submit such a proposal. That we have not seen any notable progress over the last 5 months leads us to believe no such proposal is forthcoming. The Special Committee is therefore unwilling to consider further extensions, and the Board agrees with the Special Committee’s determination.

While we continue to wholeheartedly support the Company’s mission and believe deeply in the value of the personalized health and wellness offering that you have articulated, it is also clear that we differ on the strategic direction for the Company going forward. Because of that difference and because of your concentrated voting power, we believe that it is in the best interests of the Company’s shareholders that we resign from the Board rather than have a protracted and distracting difference of view with you as to the direction of the Company.

We are proud of what 23andMe has achieved in pioneering direct access to genetic information, and we have been honored to have had the opportunity to be part of those efforts.

Sincerely,

/s/

Roelof Botha, Patrick Chung, Sandra HernΓ‘ndez, M.D., Neal Mohan, Valerie Montgomery Rice M.D., Richard Scheller, Ph.D., Peter J. Taylor

About 23andMe

23andMe is a genetics-led consumer healthcare and biopharmaceutical company empowering a healthier future. For more information, please visit www.23andMe.com.
πŸ‘οΈ0
Pisd Pisd 2 months ago
..coulda woulda shoulda, run into the ground..too bad ...
πŸ‘οΈ0
Banjo50 Banjo50 2 months ago
IS THIS STOCK A SCAM OR WHAT??? I WHAT THE TRUTH!!!
πŸ‘οΈ0
BLACKBIRDSR-71 BLACKBIRDSR-71 3 months ago
FOXO EPIGENETICS AI LOW FLOATER IS THE KEYS TO AI
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
ME new 52 low
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
ME new 52 low
πŸ‘οΈ0
Pisd Pisd 6 months ago
Data on the dark web no less, useless ...
πŸ‘οΈ0
Afterhoursearnings3 Afterhoursearnings3 7 months ago
Not great, but that's part of the game friend. Sometimes you lose.
πŸ‘οΈ0
Pisd Pisd 7 months ago
..only $170M market cap, sell to highest bidder! ME$$,,,
πŸ‘οΈ0
Pisd Pisd 7 months ago
AI, law enforcement/gov, pharma want ME dna database imo...
πŸ‘οΈ0
ErnieBilco ErnieBilco 7 months ago
Corporate theft IMO. The CEO and her board of minions should be excluded from any voting on this.
πŸ‘οΈ0
Pisd Pisd 7 months ago
Let insiders take private?, voting NO here...
πŸ‘οΈ0
PapaSizz PapaSizz 7 months ago
How'd that work out?
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
It doesn’t bother me, since I have lots of money to buy shares of a company like Curtis-Wright
πŸ‘οΈ0
ErnieBilco ErnieBilco 8 months ago
Kathy Hibbs is selling about 35K shares per week but it should slow down since the price is now lower than what she gets them for. 42 cents

She only has like 115K left before they reload to feed themselves more shares
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
ME new 52 lo
πŸ‘οΈ0
ErnieBilco ErnieBilco 8 months ago
Didn't like it in the .60 and see even less to like at .44 -

I have only one question - Will it be a quick BK or a slow drawn out worthless attempt to infuse some sort of actual value?
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
ME new 52 week low
πŸ‘οΈ0
ErnieBilco ErnieBilco 9 months ago
Hey I'm a gambler but I'm not willing to put any money into this. The Q reads like a failing business venture to me. I saw absolutely no bright spots in the filing. It was worth a look to save my funds from devastating losses.
πŸ‘οΈ0
Afterhoursearnings3 Afterhoursearnings3 11 months ago
Grabbed a butt load at .8
πŸ‘οΈ0
mick mick 11 months ago
https://www.otcmarkets.com/stock/ME
πŸ‘οΈ0
mick mick 11 months ago
https://www.otcmarkets.com/stock/ME
πŸ‘οΈ0
mick mick 1 year ago
https://www.otcmarkets.com/stock/ME
πŸ‘οΈ0
Afterhoursearnings3 Afterhoursearnings3 1 year ago
Buyside bias last 5 sessions. Will pop
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
ME new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
ME new 52 week low
πŸ‘οΈ0
mick mick 1 year ago
https://www.otcmarkets.com/stock/ME
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
ME new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
ME new 52 week low
πŸ‘οΈ0
Awl416 Awl416 1 year ago
23andMe Granted New FDA Clearance to Report Additional BRCA Variants
πŸ‘οΈ0
Afterhoursearnings3 Afterhoursearnings3 1 year ago
Hammer bottom
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
ME new 52 Week low
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
ME new 52 week low
πŸ‘οΈ0
mick mick 1 year ago
ME
23andMe Holding Company
1.51
-0.015 (-0.98%)
Volume: 2,773,867
Day Range: 1.45 - 1.53
Last Trade Time: 7:59:42 PM EDT
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
ME new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
23andMe Holding Co. NASDAQ: ME

GoSymbol lookup
Health Care : Health Care Providers & Services | Small Cap BlendCompany profile
23andMe Holding Co. is a genetics-led consumer healthcare and therapeutics company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including information on customers’ genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. The Therapeutics business segment focuses on the use of genetic insights from databases of genetic and phenotypic information to develop novel therapies to improve patients’ lives. The Therapeutics segment consists of out-licensing of intellectual property associated with identified drug targets and expenses related to therapeutic product candidates.
πŸ‘οΈ0
propert propert 1 year ago
Great news today, anyone else excited by that green hammer at the close? Let's rock on Monday!
πŸ‘οΈ0
mick mick 1 year ago
ME
23andMe Holding Company
1.67
0.04 (2.45%)
Volume: 1,009,450
Day Range: 1.64 - 1.71
Last Trade Time: 7:59:13 PM EDT
πŸ‘οΈ0
mick mick 1 year ago
ME
23andMe Holding Company
1.64
0.05 (3.14%)
Volume: 7,698,993
Day Range: 1.57 - 1.65
Last Trade Time: 7:58:30 PM EDT
πŸ‘οΈ0
mick mick 1 year ago
ME
23andMe Holding Company
2.07
0.03 (1.47%)
Volume: 4,213,342
Day Range: 1.8338 - 2.10
Last Trade Time: 7:59:16 PM EDT
πŸ‘οΈ0
mick mick 2 years ago
ME
23andMe Holding Company
1.99
0.11 (5.85%)
Volume: 1,349,148
Day Range: 1.825 - 1.99
Last Trade Time: 7:36:16 PM EDT
πŸ‘οΈ0
Afterhoursearnings3 Afterhoursearnings3 2 years ago
Have 12k shares here now. The data here is extremely valuable.
👍️ 1
mick mick 2 years ago
ME
23andMe Holding Company
2.25
-0.04 (-1.75%)
Volume: 948,040
Day Range: 2.19 - 2.30
Last Trade Time: 7:56:39 PM EDT
πŸ‘οΈ0
mick mick 2 years ago
ME
23andMe Holding Company
2.25
-0.04 (-1.75%)
Volume: 948,040
Day Range: 2.19 - 2.30
Last Trade Time: 7:56:39 PM EDT
πŸ‘οΈ0
mick mick 2 years ago
ME
23andMe Holding Company
2.51
-0.08 (-3.09%)
Volume: 1,419,788
Day Range: 2.48 - 2.57
Last Trade Time: 7:24:32 PM EST
πŸ‘οΈ0
mick mick 2 years ago
ME
23andMe Holding Company
2.59
-0.28 (-9.76%)
Volume: 3,437,659
Day Range: 2.49 - 2.68
Last Trade Time: 6:25:22 PM EST
πŸ‘οΈ0
mick mick 2 years ago
ME
23andMe Holding Company
2.59
-0.28 (-9.76%)
Volume: 3,437,659
Day Range: 2.49 - 2.68
Last Trade Time: 6:25:22 PM EST
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock